Target Details
| UniProt AC | P04049 |
|---|---|
| Gene Symbol | RAF1 |
| Protein Name | RAF proto-oncogene serine/threonine-protein kinase |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00130 (C1_1) PF07714 (PK_Tyr_Ser-Thr) PF02196 (RBD) |
Summary
- Multi-target molecules 2,133
- Clinical molecules 20
- Avg pChEMBL 8.1
KEGG Pathways (84)
- Acute myeloid leukemia
- Alcoholism
- Alzheimer disease
- Apelin signaling pathway
- Apoptosis
- Autophagy - animal
- Axon guidance
- B cell receptor signaling pathway
- Bladder cancer
- Breast cancer
- C-type lectin receptor signaling pathway
- Cadherin signaling
- Cellular senescence
- Central carbon metabolism in cancer
- Chemical carcinogenesis - reactive oxygen species
- Chemical carcinogenesis - receptor activation
- Chemokine signaling pathway
- Choline metabolism in cancer
- Chronic myeloid leukemia
- Colorectal cancer
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endometrial cancer
- ErbB signaling pathway
- Estrogen signaling pathway
- Fc epsilon RI signaling pathway
- Fc gamma R-mediated phagocytosis
- Focal adhesion
- FoxO signaling pathway
- Gap junction
- Gastric cancer
- Glioma
- GnRH secretion
- GnRH signaling pathway
- Growth hormone synthesis, secretion and action
- Hepatitis B
- Hepatitis C
- Hepatocellular carcinoma
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- Human papillomavirus infection
- Influenza A
- Insulin signaling pathway
- JAK-STAT signaling pathway
- Kaposi sarcoma-associated herpesvirus infection
- Long-term depression
- Long-term potentiation
- MAPK signaling pathway
- Melanogenesis
- Melanoma
- MicroRNAs in cancer
- Natural killer cell mediated cytotoxicity
- Neurotrophin signaling pathway
- Neutrophil extracellular trap formation
- Non-small cell lung cancer
- Oxytocin signaling pathway
- PD-L1 expression and PD-1 checkpoint pathway in cancer
- PI3K-Akt signaling pathway
- Pancreatic cancer
- Parathyroid hormone synthesis, secretion and action
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Phospholipase D signaling pathway
- Progesterone-mediated oocyte maturation
- Prolactin signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Rap1 signaling pathway
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Relaxin signaling pathway
- Renal cell carcinoma
- Salmonella infection
- Serotonergic synapse
- Signaling pathways regulating pluripotency of stem cells
- Sphingolipid signaling pathway
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Tuberculosis
- VEGF signaling pathway
- Vascular smooth muscle contraction
- cAMP signaling pathway
- cGMP-PKG signaling pathway
- mTOR signaling pathway
Associated Diseases (4)
Active Molecules (2,133)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
LPFGHVPGOMOXRL
|
6.1 | IC50 | 2 | — | |
RAHBGWKEPAQNFF
|
6.1 | Kd | 26 | — | |
CTDIPKVKSWWUCY
|
6.0 | IC50 | 2 | — | |
CUIHSIWYWATEQL
|
6.0 | Kd | 61 | Yes | |
JYRJOQGKGMHTOO
|
6.0 | IC50 | 11 | — | |
YUERBQPSJHOKJZ
|
6.0 | IC50 | 2 | — | |
UPEJCLCLSGLFGB
|
6.0 | IC50 | 2 | — | |
ODPGGGTTYSGTGO
|
6.0 | Kd | 153 | — | |
OJHKFJUSIRGQQQ
|
6.0 | IC50 | 2 | — | |
SHKVYTQIJOOEMA
|
6.0 | IC50 | 6 | — | |
NGFGTMFVWSDFPS
|
6.0 | IC50 | 32 | — | |
PSTHQEKRNOGKMV
|
6.0 | IC50 | 2 | — | |
QLQOCYLHRICUMN
|
6.0 | IC50 | 2 | — | |
VDIYQHFWCBWRJR
|
6.0 | IC50 | 5 | — | |
KESTWPLUUMJUJR
|
6.0 | IC50 | 2 | — | |
KQKPLQROQOPNSH
|
6.0 | IC50 | 2 | — | |
RTOHFILATZRMIA
|
6.0 | IC50 | 2 | — | |
ABOWVCATJOQIKV
|
6.0 | IC50 | 2 | — | |
AUBUHKOMQOEJPY
|
6.0 | IC50 | 2 | — | |
BIWSAOSOLYQECL
|
6.0 | IC50 | 2 | — | |
DRRLHDVXGXINDY
|
6.0 | IC50 | 2 | — | |
DUTIZIJGZLSWNM
|
6.0 | IC50 | 2 | — | |
DZMHPXFZEYWNCN
|
6.0 | IC50 | 2 | — | |
GBDPQAFBWNXLFV
|
6.0 | IC50 | 2 | — | |
GQBDSNNFWUMJQQ
|
6.0 | IC50 | 2 | — | |
GRUIHSPTEYNYKW
|
6.0 | IC50 | 2 | — | |
HEBSEJYDCRBKHO
|
6.0 | IC50 | 2 | — | |
HPMBPVUWGMRNIX
|
6.0 | IC50 | 2 | — | |
ICONQZBKGMYHET
|
6.0 | IC50 | 2 | — | |
IDEVNKGQZFRKRC
|
6.0 | IC50 | 2 | — | |
IKLRBEWSNVBCHQ
|
6.0 | IC50 | 15 | — | |
IMOCUQOMPMIGDE
|
6.0 | IC50 | 2 | — | |
INDINDMOSREUKT
|
6.0 | IC50 | 2 | — | |
IRICHZKTBZWNJG
|
6.0 | IC50 | 2 | — | |
ISAYWFXFDWDBCC
|
6.0 | IC50 | 2 | — | |
ISHZSURCURDLIZ
|
6.0 | IC50 | 2 | — | |
IVRIHMKFJQECLE
|
6.0 | IC50 | 2 | — | |
IVYBVASORSYGEF
|
6.0 | IC50 | 2 | — | |
JBZJNOYHEUQFBK
|
6.0 | IC50 | 2 | — | |
JSMIWUUKHVQDRY
|
6.0 | IC50 | 2 | — | |
KDTAQSMAQLUPGB
|
6.0 | IC50 | 2 | — | |
KTLQDDGRBDLKMN
|
6.0 | IC50 | 5 | — | |
LKIILXJTZLQLGF
|
6.0 | IC50 | 2 | — | |
LKYXQBDSGMMSPN
|
6.0 | IC50 | 2 | — | |
MCSQGGVPYHUPET
|
6.0 | IC50 | 2 | — | |
MKVJEWXMOVKCHS
|
6.0 | IC50 | 4 | — | |
MLSWKKYTSVUACC
|
6.0 | IC50 | 2 | — | |
MPBLSRRIBYVXJE
|
6.0 | IC50 | 2 | — | |
MXIKYLOVGFIKOA
|
6.0 | IC50 | 2 | — | |
NRSGWEVTVGZDFC
|
6.0 | IC50 | 50 | — |